Biologic Injection for Lumbar Disc Herniation

This study is investigating if an injection of Bone Marrow Aspirate Concentrate (BMAC) during surgery can help adults recovering from a lumbar microdiscectomy (a surgery for a slipped disc in your lower back). BMAC is made from your own bone marrow. Researchers want to see if this injection improves the health of your spinal disc tissue, as shown on MRI scans, and if it leads to less pain and disability compared to surgery alone. You could be eligible if you are an adult aged 18 or older with a confirmed diagnosis of degenerative disc disease or a lumbar disc herniation, and your symptoms haven't improved with other treatments for over three months. The study is currently unclear on its recruitment status.

Study design
This interventional study plans to enroll 90 participants. Researchers will compare one group receiving standard surgery plus the BMAC injection with another group receiving only the standard surgery.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Your intervertebral disc hydration will be measured at 3 months, 1 year, and 2 years after your operation.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07386548

Biologic Injection For Adults With Lumbar Disc Herniation

Recruiting
NAAges 18+InterventionalTreatment
Weill Medical College of Cornell University
~90 participants
Updated 2026-07-29 on ClinicalTrials.gov
What's tested:Bone Marrow Aspirate Concentrate (BMAC)

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change from Baseline in Intervertebral Disc Hydration at 3 Months
Measured over Baseline and 3 Months post-operation
+17 more outcomes measured
Degenerative Disc Disease
DDD
Degenerative Disc Disease Lumbar
Degenerative Disc Disease, Lumbar
Lumbar Disc Herniation
Disc Herniation, Lumbar
Bone Marrow Aspirate Concentrate
Intervertebral Disc Displacement
Low Back Pain
Chronic Low Back Pain (CLBP)
CLBP - Chronic Low Back Pain
1 sites across 1 states
New York1
  • Roger Hartl, MD · PRINCIPAL_INVESTIGATOR · NewYork Presbyterian-Weill Cornell Medicine

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Male or female patients ≥ 18 years of age
Clinically and/or radiographically (MRI) confirmed diagnosis of degenerative disc disease of the lumbar spine, lumbar disc herniation, and indication for lumbar microdiscectomy surgery
Unresponsive to conservative/non-operative treatment for \>3 months
Psychosocial, mental and physical ability to understand and to adhere to this protocol, especially adhering to the visit schedule follow-ups and observe the treatment plan

Exclusion

Prisoners
Individuals who are not yet adults (infants, children, teenagers)
Individuals who are not able to clearly understand English
Adults with diminished capacity to consent
Major cognitive impairment causing to inability to understand and provide informed consent
Active malignancy
Active chronic or acute infection
Autoimmune disorder that impacts the lumbar spine (ankylosing spondylitis, lupus e.g.)
Bone marrow-derived or non-bone marrow-derived cancer
Low platelet count or clotting disorders
Prior surgery at the level to be treated or the adjacent level
  • Change from Baseline in Intervertebral Disc Hydration at 3 MonthsBaseline and 3 Months post-operation

    MRI T2 mapping and T2 relaxation time are advanced imaging techniques that help assess the hydration status of intervertebral discs. These two metrics will be combined as one data point. T2 relaxation time measures the decay of the MRI signal, which is influenced by the water content in the disc. Higher T2 values indicate better hydration, while lower T2 values suggest dehydration and degeneration. T2 mapping provides a detailed, quantitative assessment of the disc's water content, allowing for early detection of degenerative changes before they become visible on standard MRI images. This information is crucial for diagnosing the extent of disc degeneration, planning surgical interventions, and monitoring the effectiveness of treatments aimed at restoring disc health.

  • Change from Baseline in Intervertebral Disc Hydration at 1 YearBaseline and 1 year post-operation

    MRI T2 mapping and T2 relaxation time are advanced imaging techniques that help assess the hydration status of intervertebral discs. These two metrics will be combined as one data point. T2 relaxation time measures the decay of the MRI signal, which is influenced by the water content in the disc. Higher T2 values indicate better hydration, while lower T2 values suggest dehydration and degeneration. T2 mapping provides a detailed, quantitative assessment of the disc's water content, allowing for early detection of degenerative changes before they become visible on standard MRI images. This information is crucial for diagnosing the extent of disc degeneration, planning surgical interventions, and monitoring the effectiveness of treatments aimed at restoring disc health.

  • Change from Baseline in Intervertebral Disc Hydration at 2 YearsBaseline and 2 years post-operation

    MRI T2 mapping and T2 relaxation time are advanced imaging techniques that help assess the hydration status of intervertebral discs. These two metrics will be combined as one data point. T2 relaxation time measures the decay of the MRI signal, which is influenced by the water content in the disc. Higher T2 values indicate better hydration, while lower T2 values suggest dehydration and degeneration. T2 mapping provides a detailed, quantitative assessment of the disc's water content, allowing for early detection of degenerative changes before they become visible on standard MRI images. This information is crucial for diagnosing the extent of disc degeneration, planning surgical interventions, and monitoring the effectiveness of treatments aimed at restoring disc health.

  • Change from Baseline in Proteoglycan Content at 3 MonthsFrom enrollment to 3 Months post-operation

    MRI T1 rho mapping and T1 rho relaxation time are advanced imaging techniques that provide insights into the biochemical composition of intervertebral discs, particularly the proteoglycan content. T1 rho relaxation time measures the decay of the MRI signal in the presence of a spin-lock pulse, which is sensitive to interactions between water molecules and macromolecules like proteoglycans. These two metrics will be combined as one data point. Higher T1 rho values indicate higher proteoglycan content and better disc hydration, while lower values suggest degeneration and reduced proteoglycan levels. T1 rho mapping offers a detailed, quantitative assessment of these biochemical changes, allowing for early detection of disc degeneration and aiding in the evaluation of treatment efficacy.

  • Change from Baseline in Proteoglycan Content at 1 YearFrom enrollment to 1 year post-operation

    MRI T1 rho mapping and T1 rho relaxation time are advanced imaging techniques that provide insights into the biochemical composition of intervertebral discs, particularly the proteoglycan content. T1 rho relaxation time measures the decay of the MRI signal in the presence of a spin-lock pulse, which is sensitive to interactions between water molecules and macromolecules like proteoglycans. These two metrics will be combined as one data point. Higher T1 rho values indicate higher proteoglycan content and better disc hydration, while lower values suggest degeneration and reduced proteoglycan levels. T1 rho mapping offers a detailed, quantitative assessment of these biochemical changes, allowing for early detection of disc degeneration and aiding in the evaluation of treatment efficacy.

  • Change from Baseline in Proteoglycan Content at 2 YearsFrom enrollment to 2 years post-operation

    MRI T1 rho mapping and T1 rho relaxation time are advanced imaging techniques that provide insights into the biochemical composition of intervertebral discs, particularly the proteoglycan content. T1 rho relaxation time measures the decay of the MRI signal in the presence of a spin-lock pulse, which is sensitive to interactions between water molecules and macromolecules like proteoglycans. These two metrics will be combined as one data point. Higher T1 rho values indicate higher proteoglycan content and better disc hydration, while lower values suggest degeneration and reduced proteoglycan levels. T1 rho mapping offers a detailed, quantitative assessment of these biochemical changes, allowing for early detection of disc degeneration and aiding in the evaluation of treatment efficacy.

  • Change from Baseline in Disc Height Index at 3 MonthsFrom enrollment to 3 months post-operation

    Assessed via MRI, the Disc Height Index (DHI) is a measurement used in spine surgery to assess the height of an intervertebral disc. It is calculated by dividing the height of the disc at the mid-vertebral line by the height of the superior vertebral body. This index helps in evaluating the degree of disc degeneration and is often used to monitor changes before and after surgical interventions.

  • Change from Baseline in Disc Height Index at 1 YearFrom enrollment to 1 year post-operation

    Assessed via MRI, the Disc Height Index (DHI) is a measurement used in spine surgery to assess the height of an intervertebral disc. It is calculated by dividing the height of the disc at the mid-vertebral line by the height of the superior vertebral body. This index helps in evaluating the degree of disc degeneration and is often used to monitor changes before and after surgical interventions.

  • Change from Baseline in Disc Height Index at 2 YearsFrom enrollment to 2 years post-operation

    Assessed via MRI, the Disc Height Index (DHI) is a measurement used in spine surgery to assess the height of an intervertebral disc. It is calculated by dividing the height of the disc at the mid-vertebral line by the height of the superior vertebral body. This index helps in evaluating the degree of disc degeneration and is often used to monitor changes before and after surgical interventions.

  • Change from Baseline in Pfirrmann Grade at 3 MonthsFrom enrollment to 3 months post-operation

    Assessed via MRI, Pfirrmann grading is a radiological classification used to assess the severity of lumbar intervertebral disc degeneration. It categorizes disc degeneration into five grades based on specific criteria related to the appearance of the discs: Grade I: Normal disc with high signal intensity and well-defined nucleus and annulus. Grade II: Slightly degenerated disc with a normal height but a lower signal intensity in the nucleus. Grade III: Moderate degeneration with a loss of disc height and a more pronounced decrease in signal intensity. Grade IV: Severe degeneration with significant loss of disc height and a very low signal intensity. Grade V: End-stage degeneration with a collapsed disc and no visible nucleus

  • Change from Baseline in Pfirrmann Grade at 1 YearFrom enrollment to 1 year post-operation

    Assessed via MRI, Pfirrmann grading is a radiological classification used to assess the severity of lumbar intervertebral disc degeneration. It categorizes disc degeneration into five grades based on specific criteria related to the appearance of the discs: Grade I: Normal disc with high signal intensity and well-defined nucleus and annulus. Grade II: Slightly degenerated disc with a normal height but a lower signal intensity in the nucleus. Grade III: Moderate degeneration with a loss of disc height and a more pronounced decrease in signal intensity. Grade IV: Severe degeneration with significant loss of disc height and a very low signal intensity. Grade V: End-stage degeneration with a collapsed disc and no visible nucleus

  • Change from Baseline in Pfirrmann Grade at 2 YearsFrom enrollment to 2 years post-operation

    Assessed via MRI, Pfirrmann grading is a radiological classification used to assess the severity of lumbar intervertebral disc degeneration. It categorizes disc degeneration into five grades based on specific criteria related to the appearance of the discs: Grade I: Normal disc with high signal intensity and well-defined nucleus and annulus. Grade II: Slightly degenerated disc with a normal height but a lower signal intensity in the nucleus. Grade III: Moderate degeneration with a loss of disc height and a more pronounced decrease in signal intensity. Grade IV: Severe degeneration with significant loss of disc height and a very low signal intensity. Grade V: End-stage degeneration with a collapsed disc and no visible nucleus

  • Change from Baseline in Nucleus Pulposus Size at 3 MonthsFrom enrollment to 3 months post-operation

    The Nucleus Pulposus is the soft, gel-like center of an intervertebral disc, surrounded by the tougher annulus fibrosus. It plays a crucial role in absorbing shock and allowing flexibility in the spine. Assessed via MRI, the size and condition of the nucleus pulposus are indicators of disc health. A healthy nucleus pulposus is typically well-hydrated and maintains disc height, while a degenerated nucleus pulposus may shrink and lose its cushioning ability.

  • Change from Baseline in Nucleus Pulposus Size at 1 YearFrom enrollment to 1 year post-operation

    The Nucleus Pulposus is the soft, gel-like center of an intervertebral disc, surrounded by the tougher annulus fibrosus. It plays a crucial role in absorbing shock and allowing flexibility in the spine. Assessed via MRI, the size and condition of the nucleus pulposus are indicators of disc health. A healthy nucleus pulposus is typically well-hydrated and maintains disc height, while a degenerated nucleus pulposus may shrink and lose its cushioning ability.

  • Change from Baseline in Nucleus Pulposus Size at 2 YearsFrom enrollment to 2 years post-operation

    The Nucleus Pulposus is the soft, gel-like center of an intervertebral disc, surrounded by the tougher annulus fibrosus. It plays a crucial role in absorbing shock and allowing flexibility in the spine. Assessed via MRI, the size and condition of the nucleus pulposus are indicators of disc health. A healthy nucleus pulposus is typically well-hydrated and maintains disc height, while a degenerated nucleus pulposus may shrink and lose its cushioning ability.

  • Change from Baseline in NOCISCORE at 3 MonthsFrom enrollment to 3 months post-operation

    Assessed via MRI, decreases in pain biomarkers within the intervertebral disc will be measured using Magnetic Resonance Spectroscopy (MRS). MRS is non-invasive. The data is analyzed and summarized in a NOCIGRAM report, which provides an objective analysis of the pain biomarkers observed during a preoperative MRI scan. The NOCISCORE measures six biomarker ratios associated with pain generation for each disc. The scores for each disc level are categorized into NOCI+, Mild, and NOCI-, from most 'painful' to 'least painful' levels.

  • Change from Baseline in NOCISCORE at 1 YearFrom enrollment to 1 year post-operation

    Assessed via MRI, decreases in pain biomarkers within the intervertebral disc will be measured using Magnetic Resonance Spectroscopy (MRS). MRS is non-invasive. The data is analyzed and summarized in a NOCIGRAM report, which provides an objective analysis of the pain biomarkers observed during a preoperative MRI scan. The NOCISCORE measures six biomarker ratios associated with pain generation for each disc. The scores for each disc level are categorized into NOCI+, Mild, and NOCI-, from most 'painful' to 'least painful' levels.

  • Change from Baseline in NOCISCORE at 2 YearsFrom enrollment to 2 years post-operation

    Assessed via MRI, decreases in pain biomarkers within the intervertebral disc will be measured using Magnetic Resonance Spectroscopy (MRS). MRS is non-invasive. The data is analyzed and summarized in a NOCIGRAM report, which provides an objective analysis of the pain biomarkers observed during a preoperative MRI scan. The NOCISCORE measures six biomarker ratios associated with pain generation for each disc. The scores for each disc level are categorized into NOCI+, Mild, and NOCI-, from most 'painful' to 'least painful' levels.